Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Lymphoma, Mantle-Cell
Trial Locations (14)

10065

Weill Cornell Medical College, New York

19104

University of Pennsylvania, Philadelphia

28204

Levine Cancer Institute, Charlotte

33136

University of Miami and Sylvester Comprehensive Cancer, Miami

40138

Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola Malpighi, Bologna

48109

University of Michigan Comprehensive Cancer Center Division of Hematology Oncology, Ann Arbor

53226

Froedtert and The Medical College of Wisconsin, Milwaukee

55131

Universitatsmedizin der Johannes Gutenberg- Universitat, Mainz

65101

Columbia Comprehensive Cancer Care Clinic, Jefferson City

77030

University of Texas MD Anderson Cancer Center, Houston

85054

Mayo Clinic Scottsdale, Phoenix

90603

Innovative Clinical Research Institute, Whittier

07601

Hackensack University Medical Center, Hackensack

Pl68DH

Derriford Hospital Plymouth Oncology Center Clinical, Plymouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY